HOST-EXAM Bleeding vs Ischemic Risk Index
Patient and procedural variables
Calculate the DAPT score and review selected bleeding-risk signals.
How to interpret this tool
The DAPT score estimates the balance of ischemic benefit and bleeding harm from continuing dual antiplatelet therapy beyond one year after coronary stenting in a selected population. It is not a general ACS score and should not be applied indiscriminately at the time of PCI.
DAPT score point assignments
| Variable | Points |
|---|---|
| Age ≥75 years | −2 |
| Age 65 to <75 years | −1 |
| Age <65 years | 0 |
| Current cigarette smoking | +1 |
| Diabetes mellitus | +1 |
| MI at presentation | +1 |
| Prior PCI or prior MI | +1 |
| Stent diameter <3 mm | +1 |
| Paclitaxel-eluting stent | +1 |
| CHF or LVEF <30% | +2 |
| Saphenous vein graft PCI | +2 |
Bleeding-risk signals and limitations
PRECISE-DAPT uses age, creatinine clearance, hemoglobin, WBC count, and prior spontaneous bleeding. This tool displays selected signals for review but does not calculate PRECISE-DAPT or classify a validated score ≥25.
- CrCl is estimated using Cockcroft–Gault and depends on entered weight and creatinine.
- Displayed thresholds are screening prompts, not a validated substitute for PRECISE-DAPT or ARC-HBR assessment.
- A DAPT score ≥2 does not override important bleeding risks or replace shared clinical decision-making.
References
Clinical notes
Document key findings and keep a structured record for your own reference.
My notes
Review, edit, or remove notes saved in this browser.
Report an issue
Your feedback helps us improve the reliability and usability of this clinical tool.